Endo, Vernalis set back on new migraine-drug use - MarketWatch
Published by Google Inc. September 30th, 2007 in Google FDA News, Regulatory AffairsEndo, Vernalis set back on new migraine-drug use MarketWatch - ... a non-approvable letter from the US Food and Drug Administration on their request to extend the use of their migraine-headache medication Frova. ... Endo Pharmaceuticals and Vernalis Receive Action Letter From FDA ... |